Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Molecular entities : Novartis ag save search
Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard‐of‐care TKIs in Phase III trial for newly diagnosed patients with chronic myeloid leukemia
Published: 2024-01-08 (Crawled : 07:00) - globenewswire.com
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.89%
H: 0.12%
C: -0.17%
scemblix leukemia trial response molecular
Point of Care Molecular Diagnostics Market Research Report by Product, Technology, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-27 (Crawled : 14:00) - prnewswire.com
TMO | News | $542.71 -0.83% 1.2M
|
Health Technology
|
| O: 0.74%
H: 1.51%
C: 0.88%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.61%
H: 0.03%
C: -0.32%
DHR | $236.295 -1.29% 2.2M
|
Health Technology
|
| O: -0.21%
H: 1.29%
C: 0.6%
CAH | $105.58 -0.88% 430K
|
Distribution Services
|
| O: -0.06%
H: 0.06%
C: -1.06%
BDX | $230.84 -0.59% 300K
|
Health Technology
|
| O: 0.08%
H: 0.36%
C: 0.24%
ABT | News | $104.91 -0.94% 2.8M
|
Health Technology
|
| O: 0.16%
H: 0.65%
C: 0.2%
PLXS | $94.09 0.44% 20K
|
Electronic Technology
|
| O: -0.09%
H: 0.57%
C: -0.17%
OSUR | $5.315 1.24% 110K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.11%
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
CODX | $1.15 0.88% 180K
|
Health Technology
|
| O: -1.57%
H: 2.39%
C: -6.37%
covid-19 care research global report impact diagnostics molecular market
Global Molecular Diagnostics Market Report 2022-2028: Industry to Reach $36.17 Billion by 2028 at a CAGR of 12.1%
Published: 2022-08-10 (Crawled : 21:00) - prnewswire.com
TMO | News | $542.71 -0.83% 1.2M
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -1.83%
H: 0.79%
C: -0.29%
A | $133.49 -0.79% 1.1M
|
Health Technology
|
| O: 0.25%
H: 1.67%
C: -0.72%
ILMN | $117.46 -0.7% 990K
|
Health Technology
|
| O: 0.99%
H: 2.93%
C: -0.92%
global report diagnostics molecular market
INVESTOR DEADLINE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN
Published: 2022-07-16 (Crawled : 08:20) - prnewswire.com
AMGN | $263.24 -0.31% 760K
|
Health Technology
| Email alert
Add to watchlist
MOLN | News | $3.8 8
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
NVS | News | $92.61 -0.51% 430K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
molecular
Immunomodulators Market: Trends & Opportunities | Global Industry Analysis [2021-2031] The demand in the global immunomodulators market is expected to increment at a potent CAGR during the forecast period of 2017 to 2025, which can be attributed to a number of key factors, such as increasing adoption of monoclonal antibodies, presence of strong pipeline portfolio, strong adoption of TNF-alpha inhibitors and B-cell inhibitors, advancements in the diagnostic tools, and the development of novel therapies using innovative technologies. In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market | Forecast [2021-2031] In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels. Isothermal Nucleic Acid Amplification Technology Market Analysis and Opportunity Assessment up to 2031 Wilmington, Delaware, United States: Surge in the prevalence of different infectious diseases globally is projected to create substantial opportunities for sales growth in the isothermal nucleic acid amplification technology market during the forecast period of 2021 to 2031. Medical Sensors Market to Gain US$ 32.15 Bn by 2028, Growing Awareness about Health and Fitness to Drive Global Market Wilmington, Delaware, United States: According to the report, the global medical sensors market was valued at US$ 15.23 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028. Oral Care Products Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The global oral care products market is anticipated to witness moderate growth during the forecast period between 2021 and 2031. Pharmacovigilance Market: Size | Share | Trends | Global Industry Outlook, 2031 Pharmacovigilance is a process refereeing to the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. Stoma Care Market Insights by Size, Status and Forecast 2031 Wilmington, Delaware, United States: Because of the high frequency of bladder cancer and colorectal cancer, growing number of activities to develop awareness about stoma, rising demand for stoma care and accessories, and technological developments is expected to drive global stoma care market in the near future. Structural Biology and Molecular Modeling Techniques Market | Global Industry Analysis [2021-2031] The global structural biology and molecular modeling techniques market is a novel conception in the global healthcare sector and has already made key contributions in obtaining remedies to a number of diseases. Addiction Treatment Market to Generate US$ 12 Bn by 2030 | Growth & Key Business Strategies Wilmington, Delaware, United States: According to the report, the global addiction treatment market was valued at ~US$ 6 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Antibacterial Drugs Market: Increasing Prevalence of Infectious Diseases to Drive the Market Wilmington, Delaware, United States: Bacterial drugs are the substances that may destroy or constrain the microorganism growth such as bacteria. Antifungal Drugs Market Demand and Global Competitive Insights 2031 Wilmington, Delaware, United States: The growing threat of fungal infections among a considerable chunk of the global populace is estimated to bring considerable growth prospects for the antifungal drugs market during the forecast period of 2021-2031. Bioimpendance Analysers Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The demand in the global bioimpendance analysers market is surging owing to high growth potential amongst emerging economies such as Brazil and India. Bioinformatics Services Market Worldwide Major Trend Outlook 2021 to 2031 Wilmington, Delaware, United States: The essential types of services provided by the vendors and players functional within the global bioinformatics services market include data analysis, gene expression, sequencing, database management, and discovery, among others. Biomedical Refrigerators and Freezers Market: Trends, Regional Outlook and Competitive Analysis [2021-2031]
Published: 2022-06-17 (Crawled : 08:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: 0.0%
LLY | News | $745.46 -0.71% 940K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
sales treatment care trends brazil services antibacterial growing diagnostic health expected infections technology diagnostics potential molecular cancer growth negative market bladder fungal infection in vitro
Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
Published: 2022-03-15 (Crawled : 21:00) - globenewswire.com
MOLN | News | $3.8 8
|
Professional, Scientific, and T...
|
| O: -0.2%
H: 0.24%
C: -0.46%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
als report molecular
Molecular Partners Reports Continued Progress of Ensovibep Global Clinical Program; Positive in vitro Data Demonstrating Maintained Inhibition of Delta and All Other Known Variants of Concern of SARS-CoV-2
Published: 2021-07-08 (Crawled : 06:00) - globenewswire.com
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.12%
H: 0.41%
C: 0.33%
positive molecular ensovibep sars-cov-2 in vitro
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
Published: 2021-05-27 (Crawled : 06:00) - globenewswire.com
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -0.4%
H: 0.26%
C: -0.36%
covid treatment molecular trial ensovibep
Molecular Partners Announces First Patient Dosed in a Phase 2 Clinical Trial of Ensovibep in COVID-19 Patients
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -0.41%
H: 0.67%
C: -0.63%
covid phase 2 molecular trial ensovibep
Molecular Partners and Novartis Announce Inclusion of COVID-19 Antiviral Candidate, ensovibep, in NIH-Sponsored ACTIV-3 Trial
Published: 2021-03-15 (Crawled : 10:00) - biospace.com/
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.25%
H: 1.17%
C: 1.13%
covid antiviral molecular trial ensovibep
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.